Gene · 23705
Papers3,480
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
961 to 980 of 3,480
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The emerging role of ISWI chromatin remodeling complexes in cancer. | J Exp Clin Cancer Res | 2021 | 34736517 | PubTator, text mining | PubMed |
| miRNA-200c-3p targets talin-1 to regulate integrin-mediated cell adhesion. | Sci Rep | 2021 | 34732818 | PubTator, text mining | PubMed |
| Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes. | Nat Commun | 2021 | 34725325 | PubTator, text mining | PubMed |
| BT7480, a novel fully synthetic Bicycle tumor-targeted immune cell agonist™ (Bicycle TICA™) induces tumor localized CD137 agonism. | J Immunother Cancer | 2021 | 34725211 | PubTator, text mining | PubMed |
| The Roles of Exosomes as Future Therapeutic Agents and Diagnostic Tools for Glioma. | Front Oncol | 2021 | 34722277 | PubTator, text mining | PubMed |
| Analysis of multiple gene co-expression networks to discover interactions favoring CFTR biogenesis and ΔF508-CFTR rescue. | BMC Med Genomics | 2021 | 34717611 | PubTator, text mining | PubMed |
Programmed death ligand-1 protein expression difference in basal like and non-basal like triple negative breast cancer and its association with disease free survival and overall survival: A systematic review. | Oncol Rev | 2021 | 34703525 | PubTator, text mining | PubMed |
| CDH2 mutation affecting N-cadherin function causes attention-deficit hyperactivity disorder in humans and mice. | Nat Commun | 2021 | 34702855 | PubTator, text mining | PubMed |
| The Mouse Papillomavirus Epigenetic Signature Is Characterised by DNA Hypermethylation after Lesion Regression. | Viruses | 2021 | 34696474 | PubTator, text mining | PubMed |
| High Cyclability Energy Storage Device with Optimized Hydroxyethyl Cellulose-Dextran-Based Polymer Electrolytes: Structural, Electrical and Electrochemical Investigations. | Polymers (Basel) | 2021 | 34685361 | PubTator, text mining | PubMed |
| Molecular Targets and Promising Therapeutics of Triple-Negative Breast Cancer. | Pharmaceuticals (Basel) | 2021 | 34681231 | PubTator, text mining | PubMed |
| The Coexistence of Blastocystis spp. in Humans, Animals and Environmental Sources from 2010-2021 in Asia. | Biology (Basel) | 2021 | 34681089 | PubTator, text mining | PubMed |
| Molecular Characterization of Blastocystis from Animals and Their Caregivers at the Gdańsk Zoo (Poland) and the Assessment of Zoonotic Transmission. | Biology (Basel) | 2021 | 34681082 | PubTator, text mining | PubMed |
| Generalizability of GWA-Identified Genetic Risk Variants for Metabolic Traits to Populations from the Arabian Peninsula. | Genes (Basel) | 2021 | 34681031 | PubTator, text mining | PubMed |
| ONC201 and an MEK Inhibitor Trametinib Synergistically Inhibit the Growth of Triple-Negative Breast Cancer Cells. | Biomedicines | 2021 | 34680527 | PubTator, text mining | PubMed |
| Re-Expression of Poly/Oligo-Sialylated Adhesion Molecules on the Surface of Tumor Cells Disrupts Their Interaction with Immune-Effector Cells and Contributes to Pathophysiological Immune Escape. | Cancers (Basel) | 2021 | 34680351 | PubTator, text mining | PubMed |
| MiR-873-5p: A Potential Molecular Marker for Cancer Diagnosis and Prognosis. | Front Oncol | 2021 | 34676171 | PubTator, text mining | PubMed |
| Combinative treatment of Curdione and docetaxel triggers reactive oxygen species (ROS)-mediated intrinsic apoptosis of triple-negative breast cancer cells. | Bioengineered | 2021 | 34666596 | PubTator, text mining | PubMed |
| Single-Cell Analysis of the Multicellular Ecosystem in Viral Carcinogenesis by HTLV-1. | Blood Cancer Discov | 2021 | 34661162 | PubTator, text mining | PubMed |
| Microdissection of the Bulk Transcriptome at Single-Cell Resolution Reveals Clinical Significance and Myeloid Cells Heterogeneity in Lung Adenocarcinoma. | Front Immunol | 2021 | 34659209 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23705/papers?page=49